| Financial Year |
March 31 2023 |
| Monetary Funds |
1,199,767,371.74 |
| Held-for-trading Financial Assets |
359,100,000.00 |
| Notes Receivable |
760,932,378.38 |
| Accounts Receivable |
414,047,337.65 |
| Advances to Suppliers |
68,104,143.58 |
| Other Receivables |
45,389,645.26 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
2,666,655,891.80 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
93,564,092.16 |
| Total Current Assets |
6,394,170,439.62 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
3,787,563,719.48 |
| Under-construction Projects |
817,144,276.70 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
739,360,337.17 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
1,362,290.10 |
| Deferred Income Tax Assets |
33,414.14 |
| Other Non-Current Assets |
5,362,255.24 |
| Sub-Total of Non-Current Assets |
5,391,259,772.43 |
| Total Assets |
11,785,430,212.05 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,070,856,593.47 |
| Accounts Payable |
1,038,353,965.70 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
-- |
| Taxes Payable |
6,597,811.72 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
136,745,031.56 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
33,356,824.39 |
| Other Current Liabilities |
111,844,744.66 |
| Sub-Total of Current Liabilities |
2,669,948,714.42 |
| Long-term Loans |
2,541,805,385.81 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
82,800,000.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
96,357,046.27 |
| Deferred Income Tax Liabilities |
76,574,773.20 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,000,827,447.49 |
| Total Liabilities |
5,670,776,161.91 |
| Paid-In Capital(Or Share Stock) |
1,972,100,000.00 |
| Capital Surplus |
2,178,078,353.90 |
| Surplus Reserve |
253,324,308.94 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,697,899,057.60 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,114,654,050.14 |
| Owner's Equity（Stockholder's Equity） |
6,114,654,050.14 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
11,785,430,212.05 |
